Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Profile of Trypanosoma cruzi infection in a tropical medicine reference center, Northern Italy.

Gobbi F, Angheben A, Anselmi M, Postiglione C, Repetto E, Buonfrate D, Marocco S, Tais S, Chiampan A, Mainardi P, Bisoffi Z.

PLoS Negl Trop Dis. 2014 Dec 11;8(12):e3361. doi: 10.1371/journal.pntd.0003361.

PMID:
25502927
2.

In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.

Timm BL, da Silva PB, Batista MM, da Silva FH, da Silva CF, Tidwell RR, Patrick DA, Jones SK, Bakunov SA, Bakunova SM, Soeiro Mde N.

Antimicrob Agents Chemother. 2014 Jul;58(7):3720-6. doi: 10.1128/AAC.02353-14.

PMID:
24752263
3.

Towards a paradigm shift in the treatment of chronic Chagas disease.

Viotti R, Alarcón de Noya B, Araujo-Jorge T, Grijalva MJ, Guhl F, López MC, Ramsey JM, Ribeiro I, Schijman AG, Sosa-Estani S, Torrico F, Gascon J; Latin American Network for Chagas Disease, NHEPACHA..

Antimicrob Agents Chemother. 2014;58(2):635-9. doi: 10.1128/AAC.01662-13.

PMID:
24247135
4.

Influence of parasite load on renal function in mice acutely infected with Trypanosoma cruzi.

Lemos JR, Rodrigues WF, Miguel CB, Parreira RC, Miguel RB, de Paula Rogerio A, Oliveira CJ, Chica JE.

PLoS One. 2013 Aug 12;8(8):e71772. doi: 10.1371/journal.pone.0071772.

PMID:
23951243
5.

Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptor.

Rigalli JP, Perdomo VG, Luquita MG, Villanueva SS, Arias A, Theile D, Weiss J, Mottino AD, Ruiz ML, Catania VA.

PLoS Negl Trop Dis. 2012;6(12):e1951. doi: 10.1371/journal.pntd.0001951.

PMID:
23272261
6.

Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain.

Ramos JM, Torrús D, Amador C, Jover F, Pérez-Chacón F, Ponce Y, Arjona FJ, Caro E, Martínez-Peinado C, Gallegos I, Cuadrado JM, Tello A, Gutiérrez F.

Pathog Glob Health. 2012 Oct;106(6):340-5. doi: 10.1179/2047773212Y.0000000039.

PMID:
23182138
7.

A systematic review of high quality diagnostic tests for Chagas disease.

Afonso AM, Ebell MH, Tarleton RL.

PLoS Negl Trop Dis. 2012;6(11):e1881. doi: 10.1371/journal.pntd.0001881. Review.

PMID:
23145201
8.

In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form--DB1965--against Trypanosoma cruzi infection.

da Silva CF, Batista Dda G, Oliveira GM, de Souza EM, Hammer ER, da Silva PB, Daliry A, Araujo JS, Britto C, Rodrigues AC, Liu Z, Farahat AA, Kumar A, Boykin DW, Soeiro Mde N.

PLoS One. 2012;7(1):e30356. doi: 10.1371/journal.pone.0030356.

PMID:
22291940
9.

Lack of association between blood-based detection of Trypanosoma cruzi DNA and cardiac involvement in a non-endemic area.

Norman FF, Pérez-Ayala A, Pérez-Molina JA, Flores-Chavez M, Cañavate C, López-Vélez R.

Ann Trop Med Parasitol. 2011 Sep;105(6):425-30. doi: 10.1179/1364859411Y.0000000033.

PMID:
22117851
10.

Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease.

Viotti R, Vigliano C, Alvarez MG, Lococo B, Petti M, Bertocchi G, Armenti A, De Rissio AM, Cooley G, Tarleton R, Laucella S.

PLoS Negl Trop Dis. 2011 Sep;5(9):e1314. doi: 10.1371/journal.pntd.0001314.

PMID:
21909451
11.

Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain.

Roca C, Pinazo MJ, López-Chejade P, Bayó J, Posada E, López-Solana J, Gállego M, Portús M, Gascón J; Chagas-Clot Research Group..

PLoS Negl Trop Dis. 2011 Apr 26;5(4):e1135. doi: 10.1371/journal.pntd.0001135.

PMID:
21572511
12.

The investigation of congenital infection by Trypanosoma cruzi in an endemic area of Chile: three protocols explored in a pilot project.

Zulantay I, Corral G, Guzman MC, Aldunate F, Guerra W, Cruz I, Araya A, Tapia V, Marquez F, Muñoz C, Apt W.

Ann Trop Med Parasitol. 2011 Mar;105(2):123-8. doi: 10.1179/136485911X12899838413583.

PMID:
21396248
13.

Importance of nonenteric protozoan infections in immunocompromised people.

Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D.

Clin Microbiol Rev. 2010 Oct;23(4):795-836. doi: 10.1128/CMR.00001-10. Review.

PMID:
20930074
14.

Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Batista Dda G, Batista MM, de Oliveira GM, do Amaral PB, Lannes-Vieira J, Britto CC, Junqueira A, Lima MM, Romanha AJ, Sales Junior PA, Stephens CE, Boykin DW, Soeiro Mde N.

Antimicrob Agents Chemother. 2010 Jul;54(7):2940-52. doi: 10.1128/AAC.01617-09.

PMID:
20457822
Items per page

Supplemental Content

Support Center